Abstract: The invention relates to a closure cap (1) for receptacles for receiving medical liquids, in particular receptacles filled with infusion solutions, transfusion solutions or liquids for enteral nutrition. The invention further relates to a receptacle (40) for receiving medical liquids, in particular a bottle, comprising such a closure cap. The closure cap (1) according to the invention is characterized by two injection parts (6 and 7) arranged separately from one another, each for injecting an additive. One injection part (6) serves to inject an additive with an injection syringe that has a needle (cannula), while the other injection part (7) serves to inject an additive with a needle-less injection syringe.

Abstract: The closure cap according to the invention for a container for receiving liquids, and in particular a BFS container for receiving an enteral nutrient solution, has a cover part and a rim part, with a withdrawal part for the withdrawal of a liquid, and in particular the enteral nutrient solution, being arranged in the cover part. Basically, the closure cap according to the invention may also comprise, as well as the withdrawal part, an injection part for the injection of a medicinal liquid into the enteral nutrient solution. The withdrawal part of the closure cap according to the invention has a connecting part for a spike of a flexible line of a transfer device and a closing-off part having a pierceable membrane for closing-off the recess in the connecting part.

Abstract: The invention relates to a closure cap for a container for receiving medical liquids, in particular a BFS vial which is produced by a blow-fill seal process, and to a BFS container with such a closure cap. The closure cap according to the invention has a cover part and an edge part, with an injection part arranged in the cover part. The injection part has an outwardly directed connection part with a conical recess for receiving the cone stem of a needleless injection syringe in a seal-forming manner, and an inwardly directed closure part which has a self-sealing membrane for closing the recess of the connection part. The self-sealing membrane is slotted. The closure cap according to the invention allows a liquid to be injected without use of an injection needle.

Abstract: The invention relates to a closure cap (1) for receptacles for receiving medical liquids, in particular receptacles filled with infusion solutions, transfusion solutions or liquids for enteral nutrition. The invention further relates to a receptacle (40) for receiving medical liquids, in particular a bottle, comprising such a closure cap. The closure cap (1) according to the invention is characterized by two injection parts (6 and 7) arranged separately from one another, each for injecting an additive. One injection part (6) serves to inject an additive with an injection syringe that has a needle (cannula), while the other injection part (7) serves to inject an additive with a needle-less injection syringe.

Abstract: The invention relates to a closure cap (1) for receptacles for receiving medical liquids, in particular receptacles filled with infusion solutions, transfusion solutions or liquids for enteral nutrition. The invention further relates to a receptacle (40) for receiving medical liquids, in particular a bottle, comprising such a closure cap. The closure cap (1) according to the invention is characterized by two injection parts (6 and 7) arranged separately from one another, each for injecting an additive. One injection part (6) serves to inject an additive with an injection syringe that has a needle (cannula), while the other injection part (7) serves to inject an additive with a needle-less injection syringe.

Abstract: The invention relates to a closure cap (1) for receptacles for receiving medical liquids, in particular receptacles filled with infusion solutions, transfusion solutions or liquids for enteral nutrition. The invention further relates to a receptacle (40) for receiving medical liquids, in particular a bottle, comprising such a closure cap. The closure cap (1) according to the invention is characterized by two injection parts (6 and 7) arranged separately from one another, each for injecting an additive. One injection part (6) serves to inject an additive with an injection syringe that has a needle (cannula), while the other injection part (7) serves to inject an additive with a needle-less injection syringe.

Abstract: The closure cap according to the invention for a container for receiving liquids, and in particular a BFS container for receiving an enteral nutrient solution, has a cover part and a rim part, with a withdrawal part for the withdrawal of a liquid, and in particular the enteral nutrient solution, being arranged in the cover part. Basically, the closure cap according to the invention may also comprise, as well as the withdrawal part, an injection part for the injection of a medicinal liquid into the enteral nutrient solution. The withdrawal part of the closure cap according to the invention has a connecting part for a spike of a flexible line of a transfer device and a closing-off part having a pierceable membrane for closing-off the recess in the connecting part.

Abstract: The invention relates to a parison for producing a receptacle used for holding liquids for medical applications, especially for holding infusion solutions or enteral nutrient solutions. The invention further relates to a method for producing such receptacles as well as such a receptacle. The parison according to the invention comprises a neck part (1) with an opening (1A), a wall part (2), and a bottom part (3) and is characterized in that one end of a section (5B) of an annular suspension device for suspending the receptacle is molded onto the underside of the bottom part (3). The free end of said section (5B) can be connected to the underside of the bottom part (3) such that the section (5B) is deformed and the annular suspension device is formed. First, the parison is produced, whereupon the receptacle is formed from the parison by means of a drawing and blow molding process. Preferably, the parison is produced in an injection molding process.

Abstract: The preform according to the invention for producing a container for medical fluids, which has a neck portion having an opening, which has a wall portion and which has a floor portion, is characterised in that one end of a first and a second sub-section is integrally formed on the underside of the floor portion, which ends can be connected together, following the production of the preform, to form an annular hanger for hanging the container up.

Abstract: The invention relates to a closure cap for a container for receiving medical liquids, in particular a BFS vial which is produced by a blow-fill seal process, and to a BFS container with such a closure cap. The closure cap according to the invention has a cover part and an edge part, with an injection part arranged in the cover part. The injection part has an outwardly directed connection part with a conical recess for receiving the cone stem of a needleless injection syringe in a seal-forming manner, and an inwardly directed closure part which has a self-sealing membrane for closing the recess of the connection part. The self-sealing membrane is slotted. The closure cap according to the invention allows a liquid to be injected without use of an injection needle.

Abstract: There are described novel compounds of the general formula ##STR1## in which R in position 3 or 4 is hydrogen, methyl, chlorine or bromine and R.sup.2 is C.sub.1 -C.sub.10 -alkyl, C.sub.3 -C.sub.7 -cycloalkyl or benzyl, and the pharmaceutically acceptable addition salts thereof with weak organic acids as well as a process for the preparation thereof.The compounds of formula (I) are inhibitors of thromboxane synthetase.

Abstract: New aryloxy-alkylamine derivatives of the general formula I ##STR1## in which A signifies a benzene or thiophene ring, R and R.sub.1, independently of one another, each hydrogen, alkyl, halogen, CF.sub.3 or alkoxy, R.sub.2 alkyl, cycloalkyl, alkenyl, alkynyl, alkaryl or saturated or unsaturated aliphatic or aromatic acyl, R.sub.3 and R.sub.4 in each case hydrogen, alkyl, alkenyl, alkynyl or cycloalkyl with, in each case, up to 8 C-atoms, whereby R.sub.3 and R.sub.4 can be the same or different but are not simultaneously hydrogen or R.sub.3 and R.sub.4, together with the nitrogen atom connecting them, form a 5- to 7-membered saturated ring or a saturated heterocyclic ring which can possibly contain an oxygen or nitrogen atom as a further heteroatom in the ring, whereby an additional nitrogen atom can be substituted by an alkyl radical with up to 3 C-atoms, and their acid-addition salts possess interesting pharmaceutical properties and are especially suitable as anti-arrhythmics.

Abstract: Thienyloxyalkylamine derivatives of the general formula: ##STR1## wherein --O--CH.sub.2 --CH.sub.2 --NR.sub.2 R.sub.3 is in position 4 or 5 of the thiophene ring;R.sub.1 is hydrogen, halogen, CF.sub.3, alkyl or alkoxy;R.sub.2 and R.sub.3 are the same or different and are each alkyl, cycloalkyl, alkenyl or alkynyl each having up to 8 C atoms, or NR.sub.2 R.sub.3 is a 5 to 7-membered saturated heterocyclic ring optionally containing a further hetero atom which is oxygen or nitrogen optionally substituted by an alkyl group having 1 to 3 C atoms; andn is an integer of 1 to 5; as well as their acid addition salts, are suitable for treatment of heart rhythm disturbances.

Abstract: 1-(3-(2-hydroxy-3-alkylaminopropoxy)-2-thienyl)-3-phenyl-1-propanones represented by formula (I) ##STR1## wherein R.sub.1 and R.sub.2 each represent a lower alkyl group, and a process for the preparation of the same. The compounds of the present invention are useful in the treatment of cardiac arrhythmias.